Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spinal muscular atrophy

S T Iannaccone1

  • 1Neuromuscular Disease and Neurorehabilitation, Texas Scottish Rite Hospital for Children, Dallas, USA.

Seminars in Neurology
|May 1, 1998
PubMed
Summary
This summary is machine-generated.

Spinal muscular atrophy (SMA) is a genetic disorder characterized by progressive muscle weakness. While the survival motor neuron (SMN) gene is implicated in over 98% of cases, effective therapies remain elusive, focusing on complication management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taking on the Titin: Muscle imaging as a diagnostic marker of biallelic <i>TTN-</i>related myopathy.

Journal of neuromuscular diseases·2025
Same author

Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.

Neurology·2009
Same author

Outcome of noninvasive ventilation in children with neuromuscular disease.

Neurology·2007
Same author

134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands.

Neuromuscular disorders : NMD·2005
Same author

Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy.

Neurology·2005
Same author

Epidemiology of epilepsy in Pakistan: review of literature.

JPMA. The Journal of the Pakistan Medical Association·2004
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Spinal muscular atrophy (SMA) is a group of inherited neuromuscular disorders.
  • Historically described in the 1890s, SMA presents with progressive muscle weakness and floppiness.
  • Current classification includes SMA types 1, 2, and 3 based on symptom onset age.

Purpose of the Study:

  • To provide a historical overview of Spinal Muscular Atrophy (SMA).
  • To outline the current understanding of SMA genetics and classification.
  • To describe the current management strategies for SMA.

Main Methods:

  • Review of historical medical literature and collaborative research findings.
  • Genetic linkage studies identifying chromosome 5q11.2-13.3.

Related Experiment Videos

  • Analysis of the survival motor neuron (SMN) gene in SMA patients.

    • Main Results:

    • SMA is linked to deletions in the survival motor neuron (SMN) gene in over 98% of patients.
    • Mutations in the SMN gene are also found in atypical SMA forms.
    • No effective therapy currently exists for SMA.

    Conclusions:

    • Management of SMA focuses on preventing and treating complications associated with severe muscle weakness.
    • Complications include respiratory issues, nutritional deficits, orthopedic deformities, and psychosocial challenges.
    • Further research into the SMN gene's function is needed for therapeutic development.